MFL 20/40 is a Oral Liquid in the Human Otc Drug category. It is labeled and distributed by Mass Fatloss Com. The primary component is 7-oxodehydroepiandrosterone 3-acetate; Adenosine Triphosphate Disodium; Apc-356433; Apc-356434; Cynanchum Vincetoxicum Root; Echinacea Angustifolia; Gamboge; Gelsemium Sempervirens Root; Graphite; Insulin Pork; Lactic Acid, L-; Methylcobalamin; Oyster Shell Calcium Carbonate, Crude; Phytolacca Americana Root; Pork Kidney; Pork Liver; Proteus Vulgaris; Strychnos Nux-vomica Seed; Sus Scrofa Cerebrum; Sus Scrofa Hypothalamus; Sus Scrofa Pancreas; Sus Scrofa Stomach.
| Product ID | 73253-0001_d14ce413-93d5-461c-9332-2fcca7eb2672 |
| NDC | 73253-0001 |
| Product Type | Human Otc Drug |
| Proprietary Name | MFL 20/40 |
| Generic Name | Asclepias Vincetoxicum, Echinacea (angustifolia), Hypothalamus (suis), Cerebrum Suis, Hepar Suis, Kidney (suis), Methylcobalamin, Pancreas Suis, Stomach (suis), Aacg-a, Aacg-b, Calcarea Carbonica, Gelsemium Sempervirens, Graphites, Nux Vomica, Phytolacca Decandra, Gambogia, 7-oxo-dehydroepiandrosterone 3-acetate, Adenosinum Triphosphoricum Dinatrum, Insulinum (suis), Sarcolacticum Acidum, Proteus (vulgaris) |
| Dosage Form | Liquid |
| Route of Administration | ORAL |
| Marketing Start Date | 2019-10-10 |
| Marketing End Date | 2024-10-07 |
| Marketing Category | UNAPPROVED HOMEOPATHIC / UNAPPROVED HOMEOPATHIC |
| Labeler Name | Mass Fatloss Com |
| Substance Name | 7-OXODEHYDROEPIANDROSTERONE 3-ACETATE; ADENOSINE TRIPHOSPHATE DISODIUM; APC-356433; APC-356434; CYNANCHUM VINCETOXICUM ROOT; ECHINACEA ANGUSTIFOLIA; GAMBOGE; GELSEMIUM SEMPERVIRENS ROOT; GRAPHITE; INSULIN PORK; LACTIC ACID, L-; METHYLCOBALAMIN; OYSTER SHELL CALCIUM CARBONATE, CRUDE; PHYTOLACCA AMERICANA ROOT; PORK KIDNEY; PORK LIVER; PROTEUS VULGARIS; STRYCHNOS NUX-VOMICA SEED; SUS SCROFA CEREBRUM; SUS SCROFA HYPOTHALAMUS; SUS SCROFA PANCREAS; SUS SCROFA STOMACH |
| Active Ingredient Strength | 30 [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL |
| Pharm Classes | Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Seed Storage Proteins [CS] |
| NDC Exclude Flag | N |
| Marketing Start Date | 2019-10-10 |
| Marketing End Date | 2024-10-07 |
| NDC Exclude Flag | N |
| Sample Package? | N |
| Marketing Category | unapproved homeopathic |
| Product Type | HUMAN OTC DRUG |
| Marketing Start Date | 2019-10-10 |
| Ingredient | Strength |
|---|---|
| CYNANCHUM VINCETOXICUM ROOT | 6 [hp_X]/mL |
| NDC | Brand Name | Generic Name |
|---|---|---|
| 43742-1504 | HA2CG Evolution | Asclepias Vincetoxicum, Echinacea (Angustifolia), Hypothalamus (Suis), Cerebrum Suis, Hepar Suis, Kidney (Suis), Methylcobalamin, Pancreas Suis, Stomach (Suis), AACG-A, AACG-B, Calcarea Carbonica, Gelsemium Sempervirens, Graphites, Nux Vomica, Phytolacca Decandra, Gambogia, 7-Oxo-Dehydroepiandrosterone 3-Acetate, Adenosinum Triphosphoricum Dinatrum, Insulinum (Suis), Sarcolacticum Acidum, Proteus (Vulgaris) |
| 73253-0001 | MFL | Asclepias Vincetoxicum, Echinacea (Angustifolia), Hypothalamus (Suis), Cerebrum Suis, Hepar Suis, Kidney (Suis), Methylcobalamin, Pancreas Suis, Stomach (Suis), AACG-A, AACG-B, Calcarea Carbonica, Gelsemium Sempervirens, Graphites, Nux Vomica, Phytolacca Decandra, Gambogia, 7-Oxo-Dehydroepiandrosterone 3-Acetate, Adenosinum Triphosphoricum Dinatrum, Insulinum (Suis), Sarcolacticum Acidum, Proteus (Vulgaris) |